Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke
Sponsor: Xinqiao Hospital of Chongqing
Summary
In patients with acute ischemic stroke secondary to large vessel occlusion, the role of intravenous adjunctive medications, such as tirofiban, or alteplase before endovascular thrombectomy has not been well investigated. This trial aim to evaluate the efficacy and safety of intravenous tirofiban versus alteplase for acute ischemic stroke patients with large vessel occlusion piror to endovascular thrombectomy.
Official title: Intravenous Adjuvant With Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Acute Ischemic Stroke Patients With Large Vessel Occlusion: a Multicenter, Open Label, Randomized Controlled Trial.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
800
Start Date
2023-11-28
Completion Date
2026-07-31
Last Updated
2025-12-26
Healthy Volunteers
No
Conditions
Interventions
Tirofiban
Intravenous tirofiban before endovascular thrombectomy.
Alteplase
Intravenous alteplase before endovascular thrombectomy.
Locations (1)
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China